Navigation Links
Mercy Lab Offers Faster On-demand Diabetes Testing, Cellular Studies
Date:6/19/2013

s platform was the original Lavender Top Management, and we were able to achieve all our expected productivity gains. The XN-9000 allows us to continue to improve even further."

New System Incorporates Latest in Automation Technology

The XN-9000, a scalable, configurable automation system, integrates multiple XN modules, including the Sysmex RU-20™ concentrated reagent dilution unit; sample sorting and archiving provided by the PVT LabSystems® TS-500; WAM™ decision support software; and Bio-Rad's VARIANT™ II TURBO Link for on-demand HbA1c testing.

With its new system, Mercy will also perform:

  • NRBCs (fluorescent nucleated red blood cell count) with every CBC (complete blood count)
  • IG (Immature granulocyte enumeration) with every differential
  • RET-He (Reticulocyte hemoglobin) as a parameter in the reticulocyte profile
  • IPF (Immature platelet fraction) to aid clinicians in the assessment of thrombocytopenia

XN-9000 Plays Critical Role in Determining Diabetes Control

The XN-9000 uses HPLC (high-performance liquid chromatography) technology – the gold standard for HbA1c testing – to perform HbA1c analysis, which measures the amount of glucose attached to the hemoglobin in the red blood cell and estimates blood glucose control during the previous three to four months. 

According to the American Diabetes Association, diabetes affects more than 25 million children and adults in the United States, or 8.3 percent of the population. It can increase a person's risk for developing serious complications, including heart disease and stroke, high blood pressure, blindness, kidney and nervous system diseases. Proper management of the chronic condition can delay or even prevent the onset of complications, allowing patients to live healthier, more pr
'/>"/>

SOURCE MERCY MEDICAL CENTER
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology news :

1. Mercyhurst Universitys new DNA sequencer to accelerate scientific research in region
2. Mercyhurst University study probes impact of climate change on ectotherms
3. Grant furthers Mercyhurst research for human pathogens in Great Lakes
4. Gene offers an athletes heart without the exercise
5. New report offers science-based strategies for management of western free-ranging horses and burros
6. Philips CX50 xMATRIX now offers world-class interventional and diagnostic features on single portable system
7. AegisCare Offers Specialized Home Health Care for Dementia and Alzheimers Patients
8. Bird flu mutation study offers vaccine clue
9. Researcher offers clues on the origins of life
10. Peach genome offers insights into breeding strategies for biofuels crops
11. Study offers new insights on invasive fly threatening US fruit crops
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/15/2014)... The German Gauß-Allianz has admitted Johannes Gutenberg University ... the Rhineland-Palatinate science hub continues to maintain a ... computing. , "The acceptance of Johannes Gutenberg ... Gauß-Allianz is a milestone in the national and ... support. The state of Rhineland-Palatinate can be proud ...
(Date:10/15/2014)... Geneticist Fred Alt will be awarded the 44th Rosenstiel ... University for his pioneering research exploring the mechanisms of ... and cancer cells. Alt is the second alumnus to ... the Nobel Prize in 2003. , Alt is the ... Genetics at Harvard Medical School and an investigator at ...
(Date:10/14/2014)... ATHENS, Ohio (Oct. 14, 2014)—It,s been millions of years ... but a team led by Ohio University scientists is ... to model airflow through dinosaur snouts. The research has ... not only breathe but to enhance the sense of ... pretty ,nosy, animals," said Ohio University doctoral student Jason ...
Breaking Biology News(10 mins):Johannes Gutenberg University Mainz joins Germany's Gauss-Allianz as a full member 2Johannes Gutenberg University Mainz joins Germany's Gauss-Allianz as a full member 3Brandeis awards 44th Rosenstiel Award to pioneering geneticist Fred Alt 2Dinosaur breathing study shows that noses enhanced smelling and cooled brain 2Dinosaur breathing study shows that noses enhanced smelling and cooled brain 3
... major greenhouse gas carbon dioxide (CO2) from industrial plants ... is on the verge of becoming a commercial reality. Several ... U.S. are leading the way, according to an article in ... the American Chemical Society. Alex Scott, C&EN,s senior editor ...
... WEST BEND, Wis. , Nov. 6, 2013 ... organization focused on driving value for clients through technology and ... collaboration platform to help manage the execution of ... The Spaulding Clinical team is using ...
... squishy gel that when compressed like at a ... material could someday deliver medications when and where osteoarthritis ... ACS journal Biomacromolecules . Xinqiao Jia, Chandran ... few decades, researchers have been developing a variety of ...
Cached Biology News:Projecis Cloud-based Collaboration Platform Selected by Spaulding Clinical to Manage Phase I Clinical Trial Projects and Timelines 2Projecis Cloud-based Collaboration Platform Selected by Spaulding Clinical to Manage Phase I Clinical Trial Projects and Timelines 3
(Date:10/25/2014)... (PRWEB) October 24, 2014 SonaCare ... focused ultrasound (HIFU) technology, announced that its Board ... as Chief Executive Officer, President and member of ... Dr. Carol will take-on expanded responsibilities within the ... as well as overseeing commercialization, manufacturing and finance. ...
(Date:10/25/2014)... 25, 2014 Berkshire Corporation, the ... to announce the release of the ValuSeal® IonX™ ... of contamination containment in critical processing applications. , ... higher cleanroom environments, ValuSeal® IonX™ is a laser ... wiper that continues Berkshire’s innovative focus on meeting ...
(Date:10/25/2014)... and NEW YORK ... Inc. (OTCQB: ACCPD), formerly Access Pharmaceuticals, Inc. (ACCP), ... areas, announced it has implemented a 1-for-50 reverse ... opening of trading on Friday, October 24, 2014. ... basis under new CUSIP number 72754H109 and temporary ...
(Date:10/25/2014)... LONDON , October 24, 2014 ... CytRx Corporation (NASDAQ: CYTR ), Vertex Pharmaceuticals ... (NASDAQ: ALXN ), Peregrine Pharmaceuticals Inc. (NASDAQ: ... Free research on these five companies can be accessed ... on Thursday, October 23, 2014, ended on a positive ...
Breaking Biology Technology:SonaCare Medical Board of Directors Appoints Dr. Mark Carol as CEO and President 2SonaCare Medical Board of Directors Appoints Dr. Mark Carol as CEO and President 3Ions Are Bygones, Berkshire Announces the Release of New Innovative Cleanroom Wipers 2PlasmaTech Biopharmaceuticals, Inc. Announces Reverse Stock Split, Ticker Change and Launches New Corporate Website 2Biotech Stocks Technical Data - CytRx, Vertex Pharma, Alexion Pharma, Peregrine Pharma, and StemCells 2Biotech Stocks Technical Data - CytRx, Vertex Pharma, Alexion Pharma, Peregrine Pharma, and StemCells 3Biotech Stocks Technical Data - CytRx, Vertex Pharma, Alexion Pharma, Peregrine Pharma, and StemCells 4Biotech Stocks Technical Data - CytRx, Vertex Pharma, Alexion Pharma, Peregrine Pharma, and StemCells 5
MAb to Vasopressin Preservative: NaN3...
... Anti-AP-2 α, clone 8G8/5 GenBank Accession ... made human AP-2alpha/gamma fusion protein corresponding to ... 278-450 of human AP-2γ Formulation: 0.1M Tris-glycine, ... before the addition of glycerol to 30% ...
Mouse monoclonal [1C6/2] to Rad17 ( Abpromise for all tested applications). entrezGeneID: 5884 SwissProtID: Q9UPF5...
MMP-2 / MMP-9 Inhibitor IV is a potent, selective, slow binding and mechanism based inhibitor of human gelatinases. • Molecular weight: 306.4 • Molecular Formula: C(15)H(14)O(3)S(2). &bul...
Biology Products: